Search Results

Press Releases

Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2024

December 10, 2024

·

9 min read

Press Releases

Cellipont Bioservices and Xiogenix Announce Strategic Partnership to Enhance Client Access to Advanced Filling Systems

December 10, 2024

·

3 min read

Biotech Beach

Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance

Avid Bioservices, Inc. announced that the company has achieved a Committed Badge from EcoVadis, one of the world’s most trusted providers of business sustainability ratings.

May 23, 2024

·

2 min read

Business

Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference

September 12, 2024

·

1 min read

Biotech Beach

Avid Bioservices to Participate at Upcoming May 2024 Investor Conferences

Avid Bioservices, Inc., a dedicated biologics contract development and manufacturing organization working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, announced that the company will participate at two upcoming investor conferences.

May 7, 2024

·

1 min read

Business

Cellipont Bioservices and Adva Biotechnology Collaborate to Optimize Cell Therapy Manufacturing with the ADVA X3® Platform

Cellipont Bioservices and Adva Biotechnology today announce its partnership with Adva Biotechnology marking the launch of the groundbreaking ADVA X3® platform in North America.

May 7, 2024

·

4 min read

Press Releases

Avid Bioservices to be Acquired by GHO Capital Partners and Ampersand Capital Partners in $1.1 Billion Transaction

November 7, 2024

·

11 min read

Business

Cellipont Bioservices Appoints Edwin Beale as Chief Commercial Officer

Cellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), today announced the appointment of Edwin Beale as its new Chief Commercial Officer, effective immediately.

March 12, 2024

·

2 min read

Press Releases

Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024

Avid Bioservices, Inc. today announced that it will report financial results for the quarter and fiscal year ended April 30, 2024, on July 2, 2024, after market close and will host a webcast at 1:30 PM Pacific Time (4:30 PM Eastern Time).

July 1, 2024

·

1 min read

Biotech Beach

Avid Bioservices Announces Pricing of Private Placement of Convertible Notes

Avid Bioservices, Inc., a dedicated biologics contract development and manufacturing organization, announced the pricing of $160 million aggregate principal amount of 7.00% Convertible Senior Notes due 2029.

March 7, 2024

·

5 min read